ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

LINDEN ADVISORS LP's Holding History (CIK: 0001279396)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 16,291,000 Value ($000) $19,102 Avg Close — Range —
Q2 2024
Shares 50,541,000 Value ($000) $54,525 Avg Close — Range —
Q1 2024
Shares 112,941,000 Value ($000) $106,339 Avg Close — Range —
Q4 2023
Shares 75,321,000 Value ($000) $74,436 Avg Close — Range —
Q3 2023
Shares 85,821,000 Value ($000) $79,544 Avg Close — Range —